From DCAT Value Chain Insights (VCI)
West Pharmaceutical Services, Inc. has appointed Eric M. Green as the company's chief executive officer (CEO), succeeding Donald E. Morel, Jr., PhD, current chairman and CEO. Eric Green will join West and take on his new responsibilities on April 24, 2015. Dr. Morel will serve as West's chairman following Mr. Green's appointment, until July 1, 2015, when he plans to formally retire.
Mr. Green joins West from Sigma-Aldrich Corporation, where he has served as executive vice president and president of the company's Research Markets business unit since 2013. In this role, Mr. Green served as a corporate officer and member of the senior executive teamwith responsibility for managing a $1.4 billion business unit, the largest at the company.
Source: West Pharmaceutical Services
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription